INMB

7.77

3.72% -0.30

Dopo l'orario di chiusura: 8.10 0.33 +4.25%

Inmune Bio Inc (INMB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$8.07

Aprire:

$7.71

Volume 24 ore:

214.58K

Relative Volume:

0.58

Capitalizzazione di mercato:

$173.12M

Reddito:

$155.00K

Utile/perdita netta:

$-30.01M

Rapporto P/E:

-4.6527

EPS:

-1.67

Flusso di cassa netto:

$-11.98M

1 W Prestazione:

+4.86%

1M Prestazione:

+0.39%

6M Prestazione:

+46.60%

1 anno Prestazione:

-23.07%

Intervallo 1D:

$7.48

$7.89

Intervallo di 1 settimana:

$7.07

$8.16

Portata 52W:

$4.32

$12.72

Inmune Bio Inc Stock (INMB) Company Profile

Nome

Inmune Bio Inc

Settore

Healthcare (1182)

Industria

Biotechnology (678)

Telefono

(858) 964-3720

Indirizzo

225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA

Dipendente

Cinguettio

@INmuneBio

Prossima data di guadagno

2025-03-25

Ultimi documenti SEC

INMB's Discussions on Twitter

Confronta INMB con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INMB Inmune Bio Inc	7.77	173.12M	155.00K	-30.01M	-11.98M	-1.67
VRTX Vertex Pharmaceuticals Inc	484.01	125.55B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	610.64	67.78B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	590.06	36.24B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	262.16	33.99B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	264.32	28.77B	3.81B	-644.79M	-669.77M	-6.24

Inmune Bio Inc Stock (INMB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-28	Iniziato	Rodman & Renshaw	Buy
2024-10-21	Iniziato	Alliance Global Partners	Buy
2024-09-27	Iniziato	Raymond James	Outperform
2024-08-22	Iniziato	Scotiabank	Sector Outperform
2023-06-01	Iniziato	Robert W. Baird	Outperform
2022-05-24	Downgrade	B. Riley Securities	Buy → Neutral
2021-07-07	Reiterato	Maxim Group	Buy
2021-04-21	Iniziato	B. Riley Securities	Buy
2021-01-22	Reiterato	Maxim Group	Buy
2020-09-01	Iniziato	BTIG Research	Buy
2020-07-15	Reiterato	H.C. Wainwright	Buy

Mostra tutto

Inmune Bio Inc Borsa (INMB) Ultime notizie

Apr 01, 2025

INmune Bio Presents MINDFuL Trial Data At AD/PD 2025 - Nasdaq

Apr 01, 2025

INmune Bio Presents Baseline Data From MINDFuL Phase II Trial In Early Alzheimer's Disease - Nasdaq

Apr 01, 2025

INmune Bio presents early Alzheimer’s trial data at AD/PD - Investing.com

Apr 01, 2025

INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study - The Manila Times

Apr 01, 2025

INmune Bio presents early Alzheimer’s trial data at AD/PD By Investing.com - Investing.com UK

Apr 01, 2025

Promising Patient Profile Emerges in Major Alzheimer's Drug Trial: 69% Carry Key Risk Gene - Stock Titan

Apr 01, 2025

Mar 31, 2025

Raymond James maintains INmune Bio stock with $23 target By Investing.com - Investing.com Australia

Mar 31, 2025

Raymond James maintains INmune Bio stock with $23 target - Investing.com India

Mar 31, 2025

Raymond James Financial Inc. Takes Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Mar 31, 2025

Mar 30, 2025

INmune Bio anticipates Alzheimer's trial results within 100 days while advancing therapeutic platforms - MSN

Mar 30, 2025

Mar 29, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 29, 2025

Mar 28, 2025

INmune Bio (INMB) Eyes Landmark Developments in 2024 Amid Rising Financial Commitments - GuruFocus

Mar 28, 2025

Earnings call transcript: INmune Bio’s Q4 2024 results highlight innovation focus - Investing.com Australia

Mar 28, 2025